Clinical Outcomes With the Only FDA-Approved Intracameral NSAID

Why use the only FDA-approved intracameral NSAID? Hear from Dr. Alex Silvester (United Kingdom) about real-world clinical and surgical outcomes with Rayner’s OMIDRIA at SpaMedica, and Dr. Eric Donnenfeld (OCLI Vision, New York) as he presents a head-to-head comparison of ketorolac levels in patients treated with OMIDRIA vs. topical drops. Watch the full video now and find more information at www.omidria.com. 

This is a studied postoperative cataract surgery regimen that may not be for everyone. Rayner does not recommend any specific combination use of products. OMIDRIA videos are for US HCPs only. Speakers may be paid Rayner Consultants.

US-OM-250001103/25